Loading company financials…
Nasdaq · Services-Commercial Physical & Biological Research · CIK 0000879169
$126.75
+1.91% · delayed 15 min
$25.15B market value
What this company does
INCYTE provides engineering, research and consulting services. It took in $5.14B last year, which makes it a mid-sized company. Of every dollar it sells, about 25 cents is left as profit.
Financial health
Strong finances across the board.
From INCYTE CORP's FY2025 annual filing · share price scored separately
Every check behind the three models, and what each one tests
Measured against FY2024, from the 10-K
Improved: +21.2%
$4.24B to $5.14B
Improved: +3845.0%
$32.6M to $1.29B
Improved: +24.3 pts
0.8% to 25.0%
It makes a profit rather than burning through money.
$1.29B earned last year
Day-to-day operations generate real cash, not just accounting profit.
$1.41B cash from operations
Sales are growing quickly.
up 21.2% on last year
A widely used bankruptcy-risk model places it well clear of distress.
Altman Z 7.90
Nothing in the filings stands out as a concern.
Filter by minute, hour, day or week
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 9% a year for the next 10 years. Over the last 7 years it grew by about 46% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 25 cents of every dollar of sales as profit, earning $1.29B last year.
What it earns, what it keeps, and what it costs to run — all from the same filing
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it earned $1.29B and generated $1.41B of cash from operations.
Reported annual figures
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Had shares withheld to cover taxes — 504 shares at $129.72 ($65.4K)
Holds 10,993 shares after this filing.
Sold on the open market — 10,801 shares at $125.56 ($1.4M)
Holds 183,200 shares after this filing.
Go deeper
Every figure above traces back to one of these filings.
Straight from SEC EDGAR — the original source for every figure above
| Filing | Filed | Covers to |
|---|---|---|
| Major event announcement(8-K) | 2026-08-31 | 2026-08-31 |
| Quarterly report(10-Q) | 2026-07-28 | 2026-06-30 |
Financial figures are from INCY's 10-K for fiscal year 2025 (period ending 2025-12-31), reported under the US GAAP taxonomy. View the source filing.
6 of 8 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. One could not be evaluated and is excluded from the total rather than counted as a failure.
7.90
In the safe zone
For this model, above 2.6 is safe and below 1.1 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +83.5%
$1.69B to $3.10B
Deteriorated: +2.6%
193.4M to 198.5M
1 other measure barely moved. Figures compare the two most recent annual filings — read the latest one. Nothing here reads the management commentary, which is where a company explains its own numbers.
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 6% and 11%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 4.7% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
Yes, quickly. Sales grew 21.2% last year.
It does not appear so. For every $1 it owes, it owns $3.89 in assets.
Around average. Investors pay $19.6 for every $1 of yearly profit.
This company has not reported enough of the required figures to calculate this score.
At a glance
Sold on the open market — 10,803 shares at $120.04 ($1.3M)
Holds 194,001 shares after this filing.
Exercised stock options — 2,207 shares at $106.47 ($235.0K)
Holds 63,648 shares after this filing.
Sold on the open market — 2,207 shares at $123.99 ($273.6K)
Holds 61,441 shares after this filing.
Sold on the open market — 10,640 shares at $122.69 ($1.3M)
Holds 204,804 shares after this filing.
Exercised stock options — 2,918 shares at $61.18 ($178.5K)
Holds 66,546 shares after this filing.
Exercised stock options — 2,284 shares at $64.25 ($146.7K)
Holds 68,830 shares after this filing.
Exercised stock options — 2,709 shares at $61.76 ($167.3K)
Holds 71,539 shares after this filing.
Exercised stock options — 3,148 shares at $68.62 ($216.0K)
Holds 74,687 shares after this filing.
Exercised stock options — 2,072 shares at $71.93 ($149.0K)
Holds 76,759 shares after this filing.
Exercised stock options — 9,459 shares at $72.27 ($683.6K)
Holds 86,218 shares after this filing.
Exercised stock options — 2,623 shares at $74.78 ($196.1K)
Holds 88,841 shares after this filing.
Exercised stock options — 2,864 shares at $77.67 ($222.4K)
Holds 91,705 shares after this filing.
Exercised stock options — 1,643 shares at $80.50 ($132.3K)
Holds 93,348 shares after this filing.
Exercised stock options — 3,023 shares at $83.20 ($251.5K)
Holds 96,371 shares after this filing.
Exercised stock options — 2,623 shares at $83.58 ($219.2K)
Holds 98,994 shares after this filing.
Exercised stock options — 1,642 shares at $85.01 ($139.6K)
Holds 100,636 shares after this filing.
Exercised stock options — 2,293 shares at $90.56 ($207.7K)
Holds 102,929 shares after this filing.
Exercised stock options — 85 shares at $106.47 ($9.0K)
Holds 103,014 shares after this filing.
Exercised stock options — 326 shares at $105.43 ($34.4K)
Holds 103,340 shares after this filing.
Sold on the open market — 14,661 shares at $119.46 ($1.8M)
Holds 88,679 shares after this filing.
Sold on the open market — 5,332 shares at $119.42 ($636.7K)
Holds 83,347 shares after this filing.
Sold on the open market — 2,187 shares at $119.47 ($261.3K)
Holds 81,160 shares after this filing.
Sold on the open market — 6,171 shares at $119.43 ($737.0K)
Holds 74,989 shares after this filing.
Sold on the open market — 4,695 shares at $119.39 ($560.5K)
Holds 70,294 shares after this filing.
Sold on the open market — 2,864 shares at $119.40 ($342.0K)
Holds 67,430 shares after this filing.
Sold on the open market — 1,643 shares at $119.51 ($196.4K)
Holds 65,787 shares after this filing.
Sold on the open market — 1,642 shares at $119.38 ($196.0K)
Holds 64,145 shares after this filing.
Sold on the open market — 85 shares at $122.19 ($10.4K)
Holds 64,060 shares after this filing.
Sold on the open market — 326 shares at $121.69 ($39.7K)
Holds 63,734 shares after this filing.
Sold on the open market — 2,293 shares at $119.41 ($273.8K)
Holds 61,441 shares after this filing.
Exercised stock options — 6,055 shares at $105.43 ($638.4K)
Holds 67,496 shares after this filing.
Sold on the open market — 6,055 shares at $120.43 ($729.2K)
Holds 61,441 shares after this filing.
Sold on the open market — 15,888 shares at $119.70 ($1.9M)
Holds 215,444 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 10,801 shares ($1.4M) on or after .
Shares originally obtained via Restricted Stock and Performance Shares.
Filed notice to sell 10,803 shares ($1.3M) on or after .
Shares originally obtained via Performance and Restricted Stock.
Filed notice to sell 2,207 shares ($273.6K) on or after .
Shares originally obtained via Stock Option Exercise.
Filed notice to sell 10,640 shares ($1.3M) on or after .
Shares originally obtained via Restricted Stock and Performance Shares.
Filed notice to sell 6,055 shares ($729.2K) on or after .
Shares originally obtained via Stock Option Exercise.
Filed notice to sell 41,899 shares ($5.0M) on or after .
Shares originally obtained via Stock Option Exercise.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
| Major event announcement(8-K) |
| 2026-07-28 |
| 2026-07-28 |
| Major event announcement(8-K) | 2026-07-06 | 2026-07-06 |
| Major event announcement(8-K) | 2026-06-22 | 2026-06-22 |
| Major event announcement(8-K) | 2026-06-09 | 2026-06-08 |
| Major event announcement(8-K) | 2026-06-08 | 2026-06-08 |
| Shareholder voting information(DEF 14A) | 2026-04-28 | 2025-12-31 |
| Quarterly report(10-Q) | 2026-04-28 | 2026-03-31 |
| Major event announcement(8-K) | 2026-04-28 | 2026-04-28 |
| Major event announcement(8-K) | 2026-03-30 | 2026-03-26 |
| Major event announcement(8-K) | 2026-03-26 | 2026-03-25 |
| Major event announcement(8-K) | 2026-03-06 | 2026-02-27 |
| Annual report(10-K) | 2026-02-10 | 2025-12-31 |
| Major event announcement(8-K) | 2026-02-10 | 2026-02-10 |
| Major event announcement(8-K) | 2025-12-12 | 2025-12-10 |
| Quarterly report(10-Q) | 2025-10-28 | 2025-09-30 |
| Major event announcement(8-K) | 2025-10-28 | 2025-10-28 |
| Major event announcement(8-K) | 2025-10-03 | 2025-09-30 |
| Major event announcement(8-K) | 2025-08-07 | 2025-08-04 |
Coverage from the last 30 days
Incyte to Present at Upcoming Investor Conferences
Yahoo Finance ·
Incyte (INCY) Just Moved, So What Is Drawing Attention Now?
Yahoo Finance ·
Incyte (INCY) Nears New ESMO Data For KRAS G12D Candidate 734
Yahoo Finance ·
Incyte Corporation (INCY) vs. Revolution Medicines (RVMD): Which Biotech Stock Offers the Better KRAS Opportunity?
Yahoo Finance ·
Incyte (INCY) Up 0.8% Since Last Earnings Report: Can It Continue?
Yahoo Finance ·
Incyte Stock: Is Wall Street Bullish or Bearish?
Yahoo Finance ·
Incyte Corporation (INCY) has the Bigger Revenue Base, but Could Halozyme Therapeutics, Inc. (HALO) have the Better Economics?
Yahoo Finance ·
Incyte Sales Growth Drives Share Price Gains
Yahoo Finance ·
Incyte (INCY) Won EU Approval For Opzelura, Has The Market Already Priced It In?
Yahoo Finance ·
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
2 Profitable Stocks with Impressive Fundamentals and 1 We Brush Off
Yahoo Finance ·
Why Is Acadia (ACAD) Up 0.5% Since Last Earnings Report?
Yahoo Finance ·
Primary sources and further research